Success.ai’s Healthcare Professionals Data for Healthcare & Hospital Executives in Europe provides a reliable and comprehensive dataset tailored for businesses aiming to connect with decision-makers in the European healthcare and hospital sectors. Covering healthcare executives, hospital administrators, and medical directors, this dataset offers verified contact details, professional insights, and leadership profiles.

With access to over 700 million verified global profiles and data from 70 million businesses, Success.ai ensures your outreach, market research, and partnership strategies are powered by accurate, continuously updated, and GDPR-compliant data. Backed by our Best Price Guarantee, this solution is indispensable for navigating and thriving in Europe’s healthcare industry.

Why Choose Success.ai’s Healthcare Professionals Data?

1. Verified Contact Data for Targeted Engagement

   • Access verified work emails, phone numbers, and LinkedIn profiles of healthcare executives, hospital administrators, and medical directors.
   • AI-driven validation ensures 99% accuracy, reducing data gaps and improving communication effectiveness.

2. Comprehensive Coverage of European Healthcare Professionals

   • Includes profiles of professionals from top hospitals, healthcare organizations, and medical institutions across Europe.
   • Gain insights into regional healthcare trends, operational challenges, and emerging technologies.

3. Continuously Updated Datasets

   • Real-time updates capture changes in leadership roles, organizational structures, and market dynamics.
   • Stay aligned with the fast-evolving healthcare landscape to identify emerging opportunities.

4. Ethical and Compliant

   • Fully adheres to GDPR, CCPA, and other global data privacy regulations, ensuring responsible and lawful data usage.

Data Highlights:

• 700M+ Verified Global Profiles: Connect with healthcare professionals and decision-makers in Europe’s hospital and healthcare sectors.
• 70M+ Business Profiles: Access detailed firmographic data, including hospital sizes, revenue ranges, and geographic footprints.
• Leadership Insights: Engage with CEOs, medical directors, and administrative leaders shaping healthcare strategies.
• Regional Healthcare Trends: Understand trends in digital healthcare adoption, operational efficiency, and patient care management.

Key Features of the Dataset:

1. Comprehensive Professional Profiles

   • Identify and connect with key players, including hospital executives, medical directors, and department heads in the healthcare industry.
   • Access data on professional histories, certifications, and areas of expertise for precise targeting.

2. Advanced Filters for Precision Campaigns

   • Filter professionals by hospital size, geographic location, or job function (administrative, medical, or operational).
   • Tailor campaigns to align with specific needs such as digital transformation, patient care solutions, or regulatory compliance.

3. Healthcare Industry Insights

   • Leverage data on operational trends, hospital management practices, and regional healthcare needs.
   • Refine product offerings and outreach strategies to address pressing challenges in the European healthcare market.

4. AI-Driven Enrichment

   • Profiles enriched with actionable data allow for personalized messaging, highlight unique value propositions, and improve engagement outcomes with healthcare professionals.

Strategic Use Cases:

1. Marketing and Outreach to Healthcare Executives

   • Promote healthcare IT solutions, medical devices, or operational efficiency tools to executives managing hospitals and clinics.
   • Use verified contact data for multi-channel outreach, including email, phone, and digital marketing.

2. Partnership Development and Collaboration

   • Build relationships with hospitals, healthcare providers, and medical institutions exploring strategic partnerships or new technology adoption.
   • Foster alliances that drive patient care improvements, cost savings, or operational efficiency.

3. Market Research and Competitive Analysis

   • Analyze trends in European healthcare to refine product development, marketing strategies, and engagement plans.
   • Benchmark against competitors to identify growth opportunities, underserved segments, and innovative solutions.

4. Recruitment and Workforce Solutions

   • Target HR professionals and hiring managers in healthcare institutions recruiting for administrative, medical, or operational roles.
   • Provide workforce optimization platforms, training solutions, or staffing services tailored to the healthcare sector.

Why Choose Success.ai?

1. Best Price Guarantee

   • Access premium-quality healthcare professional data at competitive prices, ensuring strong ROI for your marketing, sales, and strategic initiatives.

2. Seamless Integration
   ...

According to a 2024 survey, 64 percent of individuals from Switzerland assessed their healthcare quality received as very good or good, while only 12 percent of Hungarian respondents rated the healthcare quality they have access to as good or very good.

According to a 2024 survey, respondents from Switzerland had the most trust in their health system, with 61 percent of individuals trusting it to give them the best treatment. On the other hand, only nine percent of respondents in Hungary believed that they were provided with the best healthcare treatment.

This statistic displays the health care access and quality index rating in each European country in 2016. According to the data, Norway and Iceland have the best health care access and quality with a rating of 97, while with a index rating of 67 Moldova is regarded to be the worst.

According to a study in 2024, Italy's medical infrastructure and professionals were ranked as the best in Europe, scoring 98.3 out of 100. Ranked just behind was Spain with a score of 96.87. This statistic shows the ranking of European countries for medical infrastructure and professionals in 2024, by index score.

In 2022, there were 2.98 thousand hospitals in Germany. The number of hospitals in the European country has been declining almost year-on-year since the year 2000, when there were over 3.6 thousand hospitals in Germany. Healthcare indicators Expenditure on health in Germany amounted to a 11.8 percent of the Gross Domestic Product (GDP) in 2023. This share has been gradually increasing since 2000. In comparison to other European countries, this ranked Germany second in terms of health expenditure in 2022, preceded by Switzerland and followed by France, which spent 11.9 percent of its GDP on healthcare in this year. Opinion of healthcare in the country The quality of German healthcare is generally regarded as good by the German population. In a survey of 12 European countries, 42 percent of German respondents rated the quality of their accessible healthcare as good or very good, and 21 percent regarded it as poor or very poor. Although, 47 percent of those surveyed trust the quality of the treatment offered in Germany, which was lower than the trust in some other western European countries.

This statistic displays the hospital consumption of tetracyclines (J01A) for systemic use in Europe in 2023, by country. In that year, the defined daily dose (DDD) of tetracyclines per 1,000 inhabitants per day in the hospital sector in Austria amounted to 0.05.

In 2023, there were 5,177 hospital organizations operating in Russia, reflecting a slight increase from the previous year. This marks a decrease of 1,131 hospitals compared to 2010, highlighting a continuous decline from the peak of 6,343 hospitals in 2011. The number of hospitals has fluctuated over the years, with the lowest count recorded in 2021 at 5,072. Hospital bed density in Russia The density of hospital beds in Russia, measured as the number of beds per 10,000 population, saw a decrease in recent years and reached 77.5 in 2023. In fact, Russia has one of the highest hospital bed densities worldwide, ranking above other Central and Eastern European (CEE) countries. Russian health care in a global context In 2024, Russia ranked 14th among the countries with the best medical infrastructure and healthcare professionals (HCPs) with an index score exceeding that of Germany and Canada. Moreover, Russia ranked 14th in terms of medicine affordability and availability.

In 2023, the United States had the highest per capita health expenditure among OECD countries. At that time, per capita health expenditure in the U.S. amounted over 13,432 U.S. dollars, significantly higher than in Switzerland, the country with the second-highest per capita health expenditure. Norway, Germany and Austria are also within the top five countries with the highest per capita health expenditure. The United States also spent the highest share of it’s gross domestic product on health care, with 16.5 percent of its GDP spent on health care services. Health Expenditure in the U.S. The United States is the highest spending country worldwide when it comes to health care. In 2022, total health expenditure in the U.S. exceeded four trillion dollars. Expenditure as a percentage of GDP is projected to increase to approximately 20 percent by the year 2031. Distribution of Health Expenditure in the U.S. Health expenditure in the United States is spread out across multiple categories such as nursing home facilities, home health care, and prescription drugs. As of 2022, the majority of health expenditure in the United States was spent on hospital care, accounting for a bit less than one third of all health spending. Hospital care was followed by spending on physician and clinical services which accounted for 20 percent of overall health expenditure.

Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.

The difficulties of death figures

This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.

Where are these numbers coming from?

The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.

Among member countries of the Organization of Economic Co-operation and Development (OECD), Japan has the highest density of magnetic resonance imaging (MRI) units. Over 57 such units are available per every million of its population. The United States and Greece both follow with rates of around 38 per million inhabitants. Compared to these countries, Mexico had around three MRI units per every million, The density of diagnostic imaging units can be one measurement to define the quality of a country’s health care infrastructure. Why and when MRI is usedThe invention of MRI scanners revolutionized diagnostic imaging as it doesn’t use radiation, but a magnetic field and radio waves. Since ionized radiation as used in CT-scans and X-rays is potentially harmful for the patient, this includes a significant advantage for MRIs. MRI scans are principally used for imaging organs, soft tissues, ligaments, and other parts of the body which are difficult to see. While on the other hand, computer tomography (CT) scanners are more frequently used to show bony structures. Among the global top manufacturers of MRI scanners are General Electric, Siemens, Hitachi, and Philips. The costs of MRIA single scan per MRI could cost up to 4,000 U.S. dollars, and thus double the cost of a scan with CT. The purchase of an MRI scanner could be a major investment for a practice or a hospital, with prices ranging from 150 thousand dollars up to several million dollars. Of course, there are installation and maintenance costs to be taken into account as well. With nearly 40 million MRI scans performed annually in the United States, it’s clear that diagnostic imaging costs are substantial.

By 2023, the alternative medicine industry revenue is expected to amount to some 30.6 billion U.S. dollars in the United States. This statistic shows a compilation of actual, estimated, and projected U.S. alternative healthcare providers and services annual revenues in between 2013 and 2023. The term alternative medicine means any form of medicine that is outside the mainstream of western or conventional medicine as practiced by the majority of physicians, in hospitals, etc. Well-known examples of alternative medicine are: homeopathy, osteopathy, and acupuncture.

Public opinion on alternative medicine Public opinion around using alternative medicine in the United States has generally been positive. A majority of men and women in the United States has reported that they were open-minded about using alternative medicine. By political affiliation, public opinion on using alternative medicine doesn’t shift dramatically either, as more than 70 percent of both Republican and Democrat voters among adults, respectively, agreed that alternative medicine is a good supplement to cancer treatment.

Alternative medicine in Europe Opinions about alternative medicine in Europe vary significantly from country to country. In France, a large majority of the population stated that they had an overall good image of alternative therapy. Similarly, in the United Kingdom, osteopathy was generally viewed as definitely or possibly an effective treatment for different illnesses. However, in Germany, a vast majority of adults stated that they still prefer traditional medicine over alternative medicine.